Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06152627 · ClinicalTrials.gov registry record
Voice Therapy Per the Rehabilitation Treatment Specification System
A clinical trial of Muscle Tension Dysphonia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 600
- Enrollment target
- 5
- Study locations
NCT06152627: Recruiting study of Muscle Tension Dysphonia, sponsored by Massachusetts General Hospital.
NCT06152627 is a study of Muscle Tension Dysphonia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 600 participants, above the 145-participant average among 4 other Muscle Tension Dysphonia trials with a reported enrollment target (314% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06152627, a study of Muscle Tension Dysphonia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of care voice therapy documentation can improve outcomes for patients with muscle tension dysphonia (MTD). The main question it aims to answer is: Since the RTSS-Voice will help clinicians think about their treatment more specifically and in relation to nine evidence-based therapies, will its adoption be associated with improved outcomes? Clinicians across five voice centers will be asked to use the RTSS-Voice to document their voice therapy sessions for patients with MTD. Researchers will compare changes in outcomes between two groups of patients: those treated during the clinician's first year using the RTSS-Voice versus those treated during the clinician's second year using the RTSS-Voice.
Primary Outcome
The VHI consists of 30 Likert questions ranging from 0-4 (0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, 4 = always) that estimate how the patient's vocal function effects his/her daily life. A short-form can be used (the VHI-10) that uses a subset of 10 questions from the 30 total questions. This patient-reported outcome measure will be used to evaluate if the patients perceive that therapy helped them function better in their activities of daily living.
Conditions Studied
Interventions
- BEHAVIORAL Standard of care voice therapy with novice clinician RTSS-Voice documentation
- BEHAVIORAL Standard of care voice therapy with expert clinician RTSS-Voice documentation
Study Locations (5)
Georgia
- Emory University - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
New York
- New York University - New York
Utah
- University of Utah - Salt Lake City
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2027-06-29 |
What NCT06152627 shows while recruiting
NCT06152627 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 145-participant average among 4 other Muscle Tension Dysphonia trials with a reported enrollment target (314% higher).
The record links to 1 condition, with Muscle Tension Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which Standard of care voice therapy with novice clinician RTSS-Voice documentation is the first listed.
NCT06152627 lists 5 locations in 5 states (Georgia, Massachusetts, New York).
Frequently Asked Questions
What is clinical trial NCT06152627 about?
NCT06152627 is a clinical study titled "Voice Therapy Per the Rehabilitation Treatment Specification System". The goal of this study is to evaluate if using evidence-based, standard ingredient and target codes from the Rehabilitation Treatment Specification System - Voice Therapy (RTSS-Voice) in standard of care voice therapy documentation can improve outcomes for patients with muscle tension dysphonia (MTD...
What is the current status of trial NCT06152627?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2026-02-03. Estimated completion is 2027-06-29.
What conditions does trial NCT06152627 study?
This clinical trial studies the following conditions: Muscle Tension Dysphonia.
What interventions are being tested in trial NCT06152627?
The interventions under investigation include: Standard of care voice therapy with novice clinician RTSS-Voice documentation (BEHAVIORAL), Standard of care voice therapy with expert clinician RTSS-Voice documentation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06152627?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06152627 being conducted?
This trial has 5 study locations across Georgia, Massachusetts, New York, Utah, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Tension Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Project 4: Ambulatory Biofeedback and Voice Therapy for Patients With Vocal Hyperfunction
RECRUITING · Early Phase 1
-
Imaging Genetics of Laryngeal Dystonia
RECRUITING
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI